Table 1

Baseline characteristics and vital parameters on admission in patients hospitalised for COVID-19, stratified by quartiles of baseline sST2 concentrations (n=123)

sST2 range (ng/mL)sST2 Q1sST2 Q2sST2 Q3sST2 Q4P value for trend
n=31n=31n=31n=30
22–3738–4849–6767 ->200
Age, years54.9±14.457.5±15.459.0±16.567.3±11.60.002
Male sex, n (%)12 (38.7)17 (54.8)20 (64.5)23 (76.7)0.002
White race, n (%)16 (51.6)13 (41.9)16 (51.6)23 (76.7)0.037
Body mass index, kg/m228.6±6.328.0±5.229.5±6.527.1±3.10.49
Obesity, n (%)7 (22.6)9 (31.0)9 (30.0)7 (23.3)0.96
Diabetes mellitus, (%)3 (9.7)4 (12.9)4 (12.9)10 (33.3)0.021
Hypertension, (%)6 (19.4)7 (23.3)10 (32.3)16 (55.2)0.002
Cardiovascular disease, (%)3 (9.7)4 (12.9)4 (12.9)7 (23.3)0.16
Chronic kidney disease, n (%)1 (3.2)1 (3.2)0 (0.0)7 (23.3)0.007
Chronic pulmonary disease, n (%)1 (3.2)2 (6.5)1 (3.2)2 (6.7)0.69
Smoking, n (%)1 (3.2)0 (0.0)1 (3.2)4 (13.3)0.06
Days of symptoms10±59±59±49±40.52
Oxygen saturation, %94±394±393±289±9<0.001
Temperature, °C38.1±1.037.9±0.938.2±0.938.2±1.00.51
Heart rate, /min88±1689±1490±1793±190.24
Respiratory rate, /min22±527±828±730±11<0.001
Systolic blood pressure, mm Hg130±13135±19133±23130±190.86
  • Values are reported as number (proportions) or mean±SD.

  • sST2, soluble ST2.